Completed

Survey on Hypoglycaemia in Insulin-treated Diabetes Patients

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
Study Aim

This survey aims to observe and determine the frequency of hypoglycaemic events in individuals who are currently managing their diabetes with insulin treatment.

What is being collected

Data Collection

Collected at a single point in time - Cross-sectional
Other
Who is being recruted

Autoimmune Diseases+6

+ Endocrine System Diseases

+ Immune System Diseases

+4 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Cohort

Tracking disease incidence in order to identify risk factors and understand disease progression over time.
Observational
Study Start: September 2012
See protocol details

Summary

Principal SponsorNovo Nordisk A/S
Last updated: December 11, 2018
Sourced from a government-validated database.Claim as a partner

Study start date: September 5, 2012

Actual date on which the first participant was enrolled.

This study is conducted in Europe. The aim of the study is to gather information about hypoglycaemia (low blood glucose) among patients with Type 1 or Type 2 diabetes mellitus. The study is both retrospective and prospective.

NCT01696266
Principal SponsorNovo Nordisk A/S
Last updated: December 11, 2018
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

29304 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Cohort

These studies follow a group of individuals with common characteristics (such as a condition or birth year) over a specific period to study health outcomes or exposures.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Autoimmune DiseasesEndocrine System DiseasesImmune System DiseasesMetabolic DiseasesNutritional and Metabolic DiseasesGlucose Metabolism DisordersDiabetes MellitusDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2

Criteria

2 inclusion criteria required to participate
Patients giving informed consent to participate in the survey
Patients with Type 1 or Type 2 diabetes mellitus treated with insulin for more than 12 months
2 exclusion criteria prevent from participating
Illiterate patients and patients otherwise unable to complete a written survey
Non-ambulatory patients

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Treatment Groups
Study Objectives

One single intervention group is designated in this study

This study does not include a placebo group 

Treatment Groups

Study Objectives

Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 24 locations

Novo Nordisk Investigational Site

Prov. de Buenos Aires, ArgentinaOpen Novo Nordisk Investigational Site in Google Maps

Novo Nordisk Investigational Site

Vienna, Austria

Novo Nordisk Investigational Site

Sofia, Bulgaria

Novo Nordisk Investigational Site

Mississauga, Canada
Completed24 Study Centers